Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

PHASE3RecruitingINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

June 2, 2027

Study Completion Date

August 25, 2027

Conditions
Pruritus
Interventions
DRUG

Dupilumab

Injection solution subcutaneous

DRUG

Placebo

Injection solution SC

DRUG

Fexofenadine (loratadine if not available)

Tablet or capsule Oral

Trial Locations (80)

100

RECRUITING

Investigational Site Number : 1580001, Taipei

235

RECRUITING

Investigational Site Number : 1580004, New Taipei City

333

RECRUITING

Investigational Site Number : 1580002, Taoyuan

833

RECRUITING

Investigational Site Number : 1580003, Kaohsiung City

1012

COMPLETED

Investigational Site Number : 0320005, Buenos Aires

1023

COMPLETED

Investigational Site Number : 0320001, Buenos Aires

1036

RECRUITING

Investigational Site Number : 3480001, Budapest

1055

COMPLETED

Investigational Site Number : 0320006, Buenos Aires

4031

RECRUITING

Investigational Site Number : 3480005, Debrecen

4558

RECRUITING

Investigational Site Number : 0320007, Maroochydore

4575

COMPLETED

Investigational Site Number : 0320003, Birtinya

6720

RECRUITING

Investigational Site Number : 3480003, Szeged

8900

RECRUITING

Investigational Site Number : 3480002, Zalaegerszeg

10029

RECRUITING

Icahn School of Medicine at Mount Sinai- Site Number : 8400034, New York

12203

RECRUITING

Investigational Site Number : 2760002, Berlin

14004

RECRUITING

Investigational Site Number : 7240004, Córdoba

15355

COMPLETED

Investigational Site Number : 4100004, Ansan-si

20016

RECRUITING

FoxHall Dermatology- Site Number : 8400042, Washington D.C.

20089

RECRUITING

Investigational Site Number : 3800002, Rozzano

20122

RECRUITING

Investigational Site Number : 3800003, Milan

21287

RECRUITING

Johns Hopkins Hospital- Site Number : 8400020, Baltimore

22100

RECRUITING

Ospedale Sant' Anna- Site Number : 8400037, Como

29420

RECRUITING

National Allergy and Asthma - North Charleston - Northside Drive- Site Number : 8400032, North Charleston

31217

RECRUITING

Skin Care Physicians of Georgia - Macon- Site Number : 8400030, Macon

31406

RECRUITING

Aeroallergy Research Laboratory- Site Number : 8400036, Savannah

32756

RECRUITING

Palm Harbor Dermatology- Site Number : 8400024, Belleair

33136

RECRUITING

University of Miami Hospital- Site Number : 8400011, Miami

36002

RECRUITING

Investigational Site Number : 7240001, Pontevedra

40241

RECRUITING

Dermatology Specialists Research (DS Research) - Kentucky- Site Number : 8400031, Louisville

42000

RECRUITING

Investigational Site Number : 3800007, Varaždin

46256

RECRUITING

Dawes Fretzin Clinical Research- Site Number : 8400007, Indianapolis

49241

COMPLETED

Investigational Site Number : 4100003, Busan

50125

RECRUITING

Investigational Site Number : 3800005, Florence

55131

RECRUITING

Investigational Site Number : 2760003, Mainz

60007

RECRUITING

Investigational Site Number : 3920001, Elk Grove Village

60020

RECRUITING

Investigational Site Number : 3800004, Torette

60590

RECRUITING

Universitätsklinikum Frankfurt- Site Number : 8400039, Frankfurt

68123

RECRUITING

The Asthma and Allergy Center- Site Number : 8400014, Bellevue

77479

RECRUITING

Complete Dermatology - Sugar Land- Site Number : 8400046, Sugar Land

80131

RECRUITING

Investigational Site Number : 3800006, Naples

92037

RECRUITING

Allergy & Rheumatology- Site Number : 8400038, La Jolla

93301

COMPLETED

Kern Allergy and Medical Research- Site Number : 8400016, Bakersfield

100191

RECRUITING

Investigational Site Number : 1560003, Beijing

200040

RECRUITING

Investigational Site Number : 1560001, Shanghai

215006

RECRUITING

Investigational Site Number : 1560011, Suzhou

310006

RECRUITING

Investigational Site Number : 1560002, Hangzhou

400016

RECRUITING

Investigational Site Number : 1560009, Chongqing

430022

RECRUITING

Investigational Site Number : 1560008, Wuhan

510018

RECRUITING

Investigational Site Number : 1560006, Guangzhou

510080

RECRUITING

Investigational Site Number : 1560005, Guangzhou

610041

RECRUITING

Investigational Site Number : 1560004, Chengdu

T2G 1B1

RECRUITING

Investigational Site Number : 1240001, Calgary

T6G 1C3

COMPLETED

Investigational Site Number : 1240008, Edmonton

N6A2C2

RECRUITING

Investigational Site Number : 1240002, London

L3P 1X2

COMPLETED

Investigational Site Number : 1240003, Markham

M4C 1L1

RECRUITING

Investigational Site Number : 1240006, Toronto

H4A 3T2

COMPLETED

Investigational Site Number : 1240005, Montreal

H4G 2L8

RECRUITING

Investigational Site Number : 1240004, Verdun

196 00

COMPLETED

Investigational Site Number : 0320004, Athens

00168

RECRUITING

Investigational Site Number : 3800001, Rome

279-0011

RECRUITING

Investigational Site Number : 3920007, Urayasu-shi

080-0013

RECRUITING

Investigational Site Number : 3920003, Obihiro

060-0063

RECRUITING

Investigational Site Number : 3920006, Sapporo

583-8588

RECRUITING

Investigational Site Number : 3920004, Habikino

593-8324

RECRUITING

Investigational Site Number : 3920002, Sakai

693-8501

RECRUITING

Investigational Site Number : 3920005, Izumo

31-033

RECRUITING

Investigational Site Number : 6160001, Krakow

50-566

RECRUITING

Investigational Site Number : 6160007, Wroclaw

51-318

ACTIVE_NOT_RECRUITING

Investigational Site Number : 6160003, Wroclaw

51-503

RECRUITING

Investigational Site Number : 6160003, Wroclaw

01-142

RECRUITING

Investigational Site Number : 6160008, Warsaw

02-172

RECRUITING

Investigational Site Number : 6160005, Warsaw

080 01

RECRUITING

Diabetol- Site Number : 8400047, Prešov

03080

COMPLETED

Investigational Site Number : 4100005, Seoul

03722

COMPLETED

Investigational Site Number : 4100002, Seoul

07441

COMPLETED

Investigational Site Number : 4100001, Seoul

08003

RECRUITING

Investigational Site Number : 7240003, Barcelona

08041

RECRUITING

Investigational Site Number : 7240006, Barcelona

03010

RECRUITING

Investigational Site Number : 7240005, Alicante

LE5 4PW

COMPLETED

Investigational Site Number : 0320002, Leicester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT05263206 - Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC) | Biotech Hunter | Biotech Hunter